Sveriges mest populära poddar

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

48 min•9 oktober 2023

Prof Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma, moderated by Dr Neil Love.

Fler avsnitt av Hematologic Oncology Update

Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review

1 apr.•25 min

CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson

23 mars•24 min

Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review

21 mars•29 min

CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah

13 mars•1 tim 3 min

Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting

11 mars•47 min

Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

9 mars•19 min

Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review

4 mars•24 min

Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

18 feb.•58 min

Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review

13 feb.•17 min

Immune Thrombocytopenia — ASH 2025 Review

6 feb.•1 tim 30 min

Hematologic Oncology Update med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.